These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14963200)

  • 1. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
    Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
    Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
    Reinhold-Keller E; Fink CO; Herlyn K; Gross WL; De Groot K
    Arthritis Rheum; 2002 Jun; 47(3):326-32. PubMed ID: 12115164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
    Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
    Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of remission in Wegener's granulomatosis with low dose methotrexate.
    de Groot K; Mühler M; Reinhold-Keller E; Paulsen J; Gross WL
    J Rheumatol; 1998 Mar; 25(3):492-5. PubMed ID: 9517769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
    Koldingsnes W; Nossent JC
    J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
    Stone JH; Tun W; Hellman DB
    J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept plus standard therapy for Wegener's granulomatosis.
    Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
    N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance.
    Langford CA; Talar-Williams C; Barron KS; Sneller MC
    Arthritis Rheum; 1999 Dec; 42(12):2666-73. PubMed ID: 10616016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
    Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
    Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
    Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
    Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
    Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.
    Langford CA; Talar-Williams C; Sneller MC
    Arthritis Rheum; 2000 Aug; 43(8):1836-40. PubMed ID: 10943874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
    Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and follow-up of localized Wegener's granulomatosis: a review of five cases.
    Nishiike S; Kato T; Nagai M; Konishi M; Sakata Y
    Acta Otolaryngol; 2004 Nov; 124(9):1103-8. PubMed ID: 15513558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.